New imaging technology could buy time for pancreatic cancer patients
Tumor shrinkage is one sign of cancer treatment’s efficacy—but Rochester scientists are exploring elasticity and permeability as well.
Anxiety cues found in the brain despite safe environment
Rochester researcher Benjamin Suarez-Jimenez and his colleagues used virtual reality to better understand how anxiety effects the brain in a ‘real-world-like’ environment.
Software uses selfies to detect early symptoms of Parkinson’s disease
Rochester computer scientist Ehsan Hoque and his colleagues have harnessed machine learning to accurately identify signs of the neurological disease by analyzing facial muscles.
Study finds evidence of COVID-19 antibodies in breast milk of vaccinated mothers
Medical Center researchers have found that mothers with both disease-acquired and mRNA vaccination-acquired immunity to COVID-19 produced breast milk with active SARS-CoV-2 antibodies.
National grant supports ‘audacious goal’ to restore vision after blindness
Rochester ophthalmology professor Juliette McGregor is leading a National Eye Institute–funded project to test therapies that regenerate the eye’s retina.
Medical Center to lead first gene therapy study for Batten disease
The University will serve as the lead study site in the US for an experimental treatment for CLN5 Batten disease, a rare and fatal neurodegenerative disorder.
A look back—and ahead—at an interdisciplinary hub for vision research
For nearly 60 years, the University’s Center for Visual Science has been transforming our understanding of vision and how we treat vision disorders.
Legacy of racism in housing policies continues to impact maternal health
Rochester economist Elaine Hill traces how redlining from decades ago in Rochester, New York, is associated with worse outcomes in pregnancy and childbirth experienced by Black women today.
Smaller is better for detecting biomarkers of trauma and cancer
Detecting tiny biomarkers circulating in our bodies is problematic and costly. Researchers are developing a cost-effective detection device using nanotechnology.
Medical Center takes part in clinical trials for mRNA flu vaccine
The University of Rochester Medical Center and Rochester General Hospital are two of only 12 sites nationally that are testing Pfizer and BioNTech’s new mRNA flu vaccine.